National Drug Schedules

Print Friendly Export to CSV

Drug Name	Comment	Schedule	Date
Macitentan or its derivatives^PDL		I	DEC / 13
Magnesium glutamate hydrobromide^PDL		I	DEC / 13
Magnesium sulfate	for parenteral use	II	SEP / 98
Magnesium sulfate in injectable form for parenteral nutrition		I	JAN / 03
Manganese and its salts	In injectable form for parenteral nutrition.	I	JAN / 03
Mannitol ^PDL	When sold and recommended for use as a diagnostic agent for the assessment of bronchial hyperresponsiveness.	I	OCT / 19
Mannitol and its salts	Except when sold and recommended for use as a diagnostic agent for the assessment of bronchial hyperresponsiveness.	II	OCT / 19
Maprotiline or its salts^PDL		I	DEC / 13
Maraviroc^PDL		I	DEC / 13
Marbofloxacin or its salts or derivatives^PDL		I	DEC / 13
Maropitant or its salts^PDL		I	DEC / 13
Mazindol^TS		I	SEP / 98
Measles vaccine		II	DEC / 98
Mebendazole^PDL	For human use.	I	DEC / 13
Mebendazole^PDL	For veterinary use - when sold to treat dogs only.	I	DEC / 13
Mecamylamine or its salts^PDL		I	DEC / 13
Mecasermin^PDL		I	MAY / 21
Mechlorethamine or its salts^PDL		I	DEC / 13
Mecillinam or its salts or derivatives^PDL	For veterinary use.	I	DEC / 13
Meclizine and its salts.	when sold in concentrations of 25 mg or less per dosage unit	III	MAY / 00
Meclizine or its salts^PDL	For human use - when sold in concentrations greater than 25 mg per dosage unit.	I	DEC / 13
Meclofenamic acid or its salts^PDL		I	DEC / 13
Mecloqualone and any salt thereof^C		I	JAN / 03
Medetomidine or its salts^PDL		I	DEC / 13
Mefenamic acid or its salts^PDL		I	DEC / 13
Mefenorex and any salt thereof^TS		I	JUN / 02
Mefloquine or its salts or derivatives^PDL		I	DEC / 13
Megestrol or its salts^PDL		I	DEC / 13
Melanoma therapeutic vaccine^PDL		I	DEC / 13
Melarsomine or its salts^PDL	For human use	I	DEC / 13
Melarsomine or its salts^PDL	For veterinary use - when sold for the treatment of heartworm in dogs.	I	DEC / 13
Meloxicam or its salts or derivatives^PDL		I	DEC / 13
Melphalan^PDL		I	DEC / 13
Memantine or its salts^PDL		I	DEC / 13
Meningococcus vaccine		II	MAR / 01
Menotropins (human)^PDL		I	DEC / 13
Mepacrine or its salts^PDL		I	DEC / 13
Mepazine or its salts^PDL		I	DEC / 13
Mephenoxalone^PDL		I	DEC / 13
Mephentermine or its salts^PDL		I	DEC / 13
Mepivacaine and its salts	for topical use on mucous membranes, except lozenges	III	SEP / 98
Mepivacaine and its salts	for ophthalmic or parenteral use	II	SEP / 98
Mepolizumab^PDL		I	AUG / 16
Meprobamate^TS		I	SEP / 98
Mepyramine	see pyrilamine	U
Mercaptopurine^PDL		I	DEC / 13
Mesna^PDL		I	DEC / 13
Mesocarb and any salt thereof^C		I	JAN / 03
Mesoridazine or its salts^PDL		I	DEC / 13
Metaldehyde^PDL		I	DEC / 13
Metaraminol bitartrate		I	SEP / 98
Metathoheptazine and its salts		II	SEP / 98
Metformin or its salts or derivatives^PDL		I	DEC / 13
Methacholine chloride^PDL		I	DEC / 13
Methadols, their salts, derivatives and salts of derivatives^N	Including: Acetylmethadol, Alphacetylmethadol, Alphamethadol, Betacetylmethadol, Betamethadol, Dimepheptanol, Noracymethadol	I	JUN / 02
Methantheline and its salts		II	SEP / 98
Methaqualone and any salt thereof^C		I	JUN / 02
Methazolamide or its salts^PDL		I	DEC / 13
Methdilazine and its salts		II	SEP / 98
Methenamine and its salts	except for topical use	II	SEP / 98
Metheptazine and its salts		II	SEP / 98
Methicillin or its salts or derivatives^PDL	For veterinary use.	I	DEC / 13
Methimazole^PDL		I	DEC / 13
Methisazone^PDL		I	DEC / 13
Methocarbamol	for parenteral use	II	SEP / 98
Methocarbamol.	except for parenteral use	III	SEP / 98
Methoin (Mephenytoin) or its salts^PDL		I	DEC / 13
Methotrexate or its salts^PDL		I	DEC / 13
Methotrimeprazine or its salts^PDL		I	DEC / 13
Methoxamine or its salts^PDL		I	DEC / 13
Methoxsalen^PDL		I	DEC / 13
Methoxy polyethylene glycol-epoetin beta^PDL		I	DEC / 13
Methoxyflurane^PDL		I	MAY / 18
Methyl salicylate	in liquid dosage forms in concentrations greater than 30%	II	SEP / 98
Methyldopa or its salts^PDL		I	DEC / 13
Methylene Blue	for parenteral use	II	SEP / 98
Methylnaltrexone or its salts^PDL	Including but not limited to methylnaltrexone bromide.	I	JUN / 15
Methylparafynol^PDL		I	DEC / 13
Methylphenidate, its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues^C	Including: Ethylphenidate; Isopropylphenidate; Propylphenidate; 3,4-Dichloromethylphenidate; 4-Methylmethylphenidate; 4-Fluoromethylphenidate; Methylnaphthidate; Ethylnaphthidate	I	JUN / 02
Methyprylon^TS		I	SEP / 98
Methysergide or its salts or derivatives^PDL		I	DEC / 13
Metoclopramide^PDL		I	DEC / 13
Metolazone or its salts^PDL		I	DEC / 13
Metomidate or its salts^PDL		I	DEC / 13
Metopimazine or its salts^PDL		I	DEC / 13
Metoprolol or its salts^PDL		I	DEC / 13
Metronidazole^PDL		I	DEC / 13
Metyrapone or its salts^PDL		I	DEC / 13
Mexiletine or its salts^PDL		I	DEC / 13
Mezlocillin or its salts or derivatives^PDL	For veterinary use	I	DEC / 13
Micafungin or its salts^PDL		I	DEC / 13
Miconazole and its salts.	for vaginal use	III	SEP / 98
Miconazole and its salts..	for topical use	U
Miconazole or its salts^PDL	For human use - except in preparations for topical or vaginal.	I	DEC / 13
Miconazole or its salts^PDL	For veterinary use.	I	DEC / 13
Midodrine or its salts^PDL		I	DEC / 13
Midostaurin or its salts^PDL		I	SEP / 17
Mifepristone or its derivatives^PDL		I	AUG / 15
Migalastat or its salts^PDL		I	DEC / 17
Miglustat^PDL		I	DEC / 13

128 result(s)

Print Friendly Export to CSV

Footnotes

C - Drug is listed in the Schedule to Part G of the Food and Drug Regulations under the Controlled Drugs and Substances Act
N - Drug is listed in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
NR - Drug has not been reviewed by the NDSAC
PDL - Drug is listed in the Health Canada Prescription Drug List
TS - Drug is listed in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
CR - Drug has been recommended for addition to the Controlled Drugs and Substances Act

National Drug Schedules

Search: National Drug Schedules

128 result(s)

Footnotes